Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
shareholders
Biotech
Judge rejects CytoDyn's motion to dismiss investor lawsuit
Investors sued CytoDyn and former executives for allegedly misleading shareholders on the status of its potential treatment for HIV and COVID-19.
Zoey Becker
Jun 27, 2025 11:53am
Italian billionaires behind Ferrari buy major stake in Philips
Aug 14, 2023 10:40am
Nymox airs dirty laundry about ex-CFO, failed deal proposal
Jul 31, 2023 1:31pm
Pardes changes hands (sort of) in wake of COVID-19 trial fail
Jul 17, 2023 9:25am
Nymox hits back at mutiny led by former execs
Jul 13, 2023 3:11pm
Cyteir calls it quits after months of cost cutting
Jun 30, 2023 10:30am
